Lv5
1050 积分 2021-04-11 加入
Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
1天前
已完结
Camrelizumab Plus Carboplatin and Pemetrexed as First-Line Treatment for Advanced Nonsquamous NSCLC: Extended Follow-Up of CameL Phase 3 Trial
1天前
已完结
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
1天前
已完结
Anlotinib may enhance the efficacy of anti-PD1 therapy by inhibiting the AKT pathway and promoting the apoptosis of CAFs in lung adenocarcinoma
2个月前
已完结
The prognostic role of WeChat-based instant doctor–patient communication in patients with advanced pancreatic cancer
2个月前
已完结
Immune Signatures of Solid Tumor Patients Treated With Immune Checkpoint Inhibitors: An Observational Study
3个月前
已完结
Understanding the global cancer statistics 2022: growing cancer burden
5个月前
已完结
Nomogram predicts survival and surgical benefits for patients with breast cancer with initial bone metastasis: A population‐based study
5个月前
已完结
Survival of small-cell lung cancer patients after surgery: A single-center retrospective cohort study
5个月前
已完结
Enhanced survival with lymphadenectomy in early-stage metachronous second primary lung cancer: A retrospective analysis
5个月前
已完结
皖公网安备34019202002308
